Esen Berrin, Coplu Nilay, Kurtoglu Demet, Gozalan Aysegul, Akin Levent
Refik Saydam National Hygiene Center, Communicable Disease Research Department, Ankara, Turkey.
J Clin Lab Anal. 2007;21(3):154-61. doi: 10.1002/jcla.20127.
Acute pertussis infection among adults can cause its transmission to the larger population, especially to infants and young children, who can develop severe disease. In order to determine an age-dependent pertussis immune response, anti-pertussis toxin (PT) antibody was detected by the indirect enzyme-linked immunosorbent assay (ELISA) method in serum samples from 2,085 healthy subjects ranging in age from 6 months to > or = 60 years. Also included in the evaluation were responses to a questionnaire including sociodemographic characteristics, vaccination, and infection history. Titers of 50-99 ELISA units (EU)/mL and of > or = 100 EU/mL were accepted as indicative for recent exposure or infection. In addition, 30 EU/mL was estimated to be a sufficient titer in women of childbearing age to protect their newborns until administration of their first dose of pertussis vaccine. After the age of 4-5 years, presence of high-titered antibodies that increase with age might be a reflection of circulating infection and indicate the magnitude of the threat to infants. According to the questionnaires, in the groups younger than 15 years old, three to four doses of diphtheria toxoid-whole cell pertussis-tetanus toxoid (DwPT) were administered in 47.2 to 77.4%, 91.2 to 100.0%, and 83.5 to 100.0% of participants in Diyarbakir, Samsun, and Antalya, respectively. In addition, up to half of the expectant mothers we studied lacked a sufficient level of estimated antibody titers. To protect infants from life-threatening pertussis infection, improving vaccination coverage to ensure herd immunity and uniformly establishing coverage throughout the country are essential. Furthermore, revaccination with acellular vaccine for schoolchildren as well as for the households of pregnant women is recommended.
成人急性百日咳感染可导致其传播至更多人群,尤其是婴幼儿,他们可能会患上严重疾病。为了确定年龄依赖性百日咳免疫反应,采用间接酶联免疫吸附测定(ELISA)法检测了2085名年龄在6个月至≥60岁之间的健康受试者血清样本中的抗百日咳毒素(PT)抗体。评估内容还包括对一份问卷的回答,问卷内容涉及社会人口学特征、疫苗接种和感染史。ELISA单位(EU)/mL滴度为50 - 99及≥100被视为近期接触或感染的指标。此外,估计育龄妇女中30 EU/mL的滴度足以保护其新生儿直至接种第一剂百日咳疫苗。4 - 5岁以后,高滴度抗体的存在且随年龄增加,可能反映了循环感染情况,并表明对婴儿的威胁程度。根据问卷,在15岁以下的人群中,迪亚巴克尔、萨姆松和安塔利亚分别有47.2%至77.4%、91.2%至100.0%和83.5%至100.0%的参与者接种了三至四剂白喉类毒素-全细胞百日咳-破伤风类毒素(DwPT)。此外,我们研究的多达一半的孕妇缺乏足够水平的估计抗体滴度。为保护婴儿免受危及生命的百日咳感染,提高疫苗接种覆盖率以确保群体免疫并在全国统一建立覆盖率至关重要。此外,建议对学童以及孕妇家庭重新接种无细胞疫苗。